Q301--VISN 19 Gene Expression Oncology Testing
Closed Pre-Solicitation Posted
- Solicitation number
- 36C25926Q0076
- Agency
-
Veterans Integrated Service Network 19
Veterans Health Administration, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Place of performance
- Department of Veterans Affairs Visn 19 Pathology and Laboratory, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs Veterans Health Administration, Veterans Integrated Service Network 19 (VISN 19) is seeking qualified sources to provide oncology gene expression reference laboratory testing services, including specimen preparation, transportation, analytical testing, performance, result reporting, and consultative services. This is a sources sought notice issued for market research purposes in accordance with Federal Acquisition Regulation Part 10, not a formal request for proposal. The VA is seeking to identify Service-Disabled Veteran-Owned Small Businesses (SDVOSB), Veteran-Owned Small Businesses (VOSB), small or emerging small businesses, and large businesses capable of fulfilling the requirement. Contractors must be approved to provide clinical diagnostic laboratory tests under both Medicare and Medicaid regulations and comply with all applicable federal and state laws. The specific gene expression tests required include Oncotype DX Breast Recurrence Score Assay, Oncotype DX Breast DCIS Score Assay, Oncotype DX Colon Recurrence Score Assay, Oncoguard Liver CPT, OncoExtra, and Cologuard CPT, or equivalent alternatives. Interested firms must submit responses electronically by November 12, 2025, at 10:00 AM Mountain Time.
This procurement is not subject to any small business set-aside designations. The notice does not identify any incumbent contractors or current service providers, nor does it disclose a specific contract award value or budget range. The services will be provided to four VA Medical Centers located in Aurora, Colorado; Fort Harrison, Montana; Oklahoma City, Oklahoma; and Salt Lake City, Utah. The procurement is classified under NAICS code 621511 (Medical Laboratories) and PSC category Q301 (Reference Laboratory Testing). While no timeline for contract performance is specified in the sources sought notice, respondents should anticipate that a formal solicitation may follow once the market research phase concludes and the VA determines the number of qualified vendors available to meet this requirement.
Notice text
THIS IS A SOURCES SOUGHT NOTICE ONLY. THIS IS NOT A REQUEST FOR PROPOSAL. The Department of Veterans Affairs, VHA, Network Contracting Office (NCO) 19 Rocky Mountain Acquisition Center is seeking potential sources that are capable of providing Oncotype Genetic (Gene Expression) Reference Lab Testing Services that includes but is not limited to: specimen preparation and storage; transportation of clinical laboratory specimens; performance of analytical testing; reporting of analytical test results; and consultative services. The Contractor shall be approved to provide clinical diagnostic laboratory tests under both Medicare and Medicaid regulations and all applicable federal and state laws.
The Contractor shall be capable of providing the following gene expression tests (OR EQUIVALENT):
a) Oncotype DX Breast Recurrence Score Assay (81519); b) Oncotype DX Breast DCIS Score Assay (0045U); c) Oncotype DX Colon Recurrence Score Assay (81525): d) Oncoguard Liver CPT (81599);
e) OncoExtra (0329U); and f) Cologuard CPT (81528)
This requirement is for the following VA Medical Centers:
Rocky Mountain Regional VA Medical Center, 1700 N. Wheeling St, Aurora, CO, 80045
VA Montana Health Care System, 3687 Veterans Dr., Fort Harrison, MT 59636
Oklahoma City VA Health Care System, 921 NE 13th St, Oklahoma City, OK, 74104
Salt Lake City VA Health Care System, 500 Foothill Drive, Salt Lake City, Ut 84148
NCO 19 is performing market research to determine if there is a sufficient number of qualified (1) Service-Disabled Veteran-Owned Small Business (SDVOSB); (2) Veteran-Owned Small Business (VOSB); (3) Small or emerging small business firms; or (4) Large businesses who can fulfill the requirement. This Sources Sought notice is issued for the purpose of market research in accordance with Federal Acquisition Regulation (FAR) Part 10. All SDVOSB, VOSB, small and large businesses capable of fulfilling the requirement are invited to respond. Any information submitted by respondents to this sources sought synopsis is voluntary. This sources sought notice is not to be construed as a commitment by the Government, nor will the Government reimburse any costs associated with the submission of information in response to this notice. Respondents will not individually be notified of the results of any Government assessments.
Responses and questions may be submitted electronically to:
Juanita.Street@va.gov and NCO19Lab@va.gov a Microsoft word compatible format no later than Wednesday, November 12th at 10:00am Mountain Time. PHONE CALLS NOT ACCEPTED.
NAICS code to be used for this acquisition is 621511. All interested firms who can MEET and FULFILL the requirements stated in the Summary of Requirements below should respond, in writing, with the following information:
Company Name:
Address:
UEI (Unique Entity ID) Number:
Contact Name:
Phone No.:
Email:
Business Size Information - Select all that applies:
Small Business
Emerging Small Business
Small Disadvantaged Business
Certified under Section 8(a) of the Small Business Act
HUBZone
Woman Owned
Certified Service-Disabled Veteran Owned Small
Veteran Owned Small Business
Large Business
Is your Company a FSS/GSA Contract Holder:
Yes No
Enter your Company s FSS/GSA Contract Number:
Enter the Effective Date/ Expiration Date of FSS/GSA Contract:
Are the proposed Genetic Oncology testing services listed and available on the above FSS/GSA Contract:
Yes No
Questions for Small Businesses ONLY:
Limitations on Subcontracting (FAR 52.219-14) What percentage of the work would be
subcontracted to another company? ________ If > 0, what is company s business size: __________
If subcontracting, what added value do you offer (FAR 52.215-23): _______________________________
Offerors capable of providing the Gene Expression Oncology tests or equivalent tests, please complete the table above and send your responses via email to Juanita.Street@va.gov and NCO19Lab@va.gov in a Microsoft word compatible format no later than Wednesday, November 12th, 10:00am Mountain Time. PHONE CALLS NOT ACCEPTED.
Files
| File | Type | Posted |
|---|---|---|
| 36C25926Q0076.docx | DOCX document |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Q301--Reference Laboratory Testing | Veterans Integrated Service Network 2 | No set-aside | |
| 6550--Cepheid GeneXpert Testing Supplies | Veterans Integrated Service Network 5 | No set-aside | |
| Purchase of Rapid Syndromic Molecular Testing Reagents for Seattle VAMC | Veterans Integrated Service Network 20 | No set-aside | |
| Emergent reference lab testing | Veterans Integrated Service Network 7 | No set-aside | |
| RFP-797-FSS-04-0001-R3: 621II Medical Laboratory Testing & Analysis Services | Veterans Integrated Service Network 12 | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity